OPKO Health, Inc. (OPK)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 02:50PM EDT. Market open.
| Previous Close | 1.3200 |
| Open | 1.3200 |
| Bid | 1.3300 x 4200 |
| Ask | 1.3500 x 200 |
| Day's Range | 1.3200 - 1.3600 |
| 52 Week Range | 0.8500 - 2.2400 |
| Volume | |
| Avg. Volume | 8,383,603 |
| Market Cap | 937.454M |
| Beta (5Y Monthly) | 1.81 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
OPKO Health's (OPK) Q1 Earnings Miss Estimates, Sales Down Y/Y
OPKO Health's (OPK) first-quarter results reflect soft performances despite robust RAYALDEE sales and strength in the Pharmaceuticals segment.
- Insider Monkey
OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript
OPKO Health, Inc. (NASDAQ:OPK) Q1 2024 Earnings Call Transcript May 7, 2024 OPKO Health, Inc. misses on earnings expectations. Reported EPS is $-0.11577 EPS, expectations were $-0.09. OPKO Health, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and […]
- Thomson Reuters StreetEvents
Q1 2024 OPKO Health Inc Earnings Call
Q1 2024 OPKO Health Inc Earnings Call
© 2024 Yahoo. All rights reserved.